Cargando…
Long‐acting implantable corticosteroid matrix for chronic rhinosinusitis: Results of LANTERN Phase 2 randomized controlled study
BACKGROUND: Topical steroids are first‐line treatment for chronic rhinosinusitis (CRS), but fail to provide adequate symptom control for all patients. Designed for medical treatment failures, LYR‐210 is an implantable matrix that locally elutes mometasone furoate to inflamed sinonasal tissue for up...
Autores principales: | Cervin, Anders, Rimmer, Joanne, Wrobel, Agnieszka, Abelak, Yogen, Brayton, Lindsay, Kuang, Yina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292908/ https://www.ncbi.nlm.nih.gov/pubmed/34534410 http://dx.doi.org/10.1002/alr.22883 |
Ejemplares similares
-
Pharmacokinetic Evidence of Steady and Sustained Drug Release from
Long-Acting Implantable Corticosteroid Matrices for Chronic
Rhinosinusitis
por: Ow, Randall A., et al.
Publicado: (2022) -
Lanterns & lances
por: Thurber, James
Publicado: (1961) -
Inflammation and Endotyping in Chronic Rhinosinusitis—A Paradigm Shift
por: Ahern, Sinead, et al.
Publicado: (2019) -
The Potential for Topical Probiotic Treatment of Chronic Rhinosinusitis, a Personal Perspective
por: Cervin, Anders U.
Publicado: (2018) -
Kircher’s Magic Lantern
Publicado: (1939)